Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician (Q34016360)

30 July 2017

1 reference

title

Tiagabine in the treatment of epilepsy--a clinical review with a guide for the prescribing physician (English)

1 reference

30 July 2017

Schmidt D

1

1 reference

30 July 2017

Gram L

2

1 reference

30 July 2017

Brodie M

3

1 reference

30 July 2017

Krämer G

4

1 reference

30 July 2017

Perucca E

5

1 reference

30 July 2017

Kälviäinen R

6

1 reference

30 July 2017

Elger CE

7

1 reference

30 July 2017

language of work or name

1 reference

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

41

1 reference

30 July 2017

3

1 reference

30 July 2017

245-251

1 reference

Tiagabine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of epilepsy

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

International experience with tiagabine add-on therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Tiagabine, SK&F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Tiagabine pharmacology in profile

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Effect of renal impairment on the pharmacokinetics and tolerability of tiagabine

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Pharmacokinetics of tiagabine, a gamma-aminobutyric acid-uptake inhibitor, in healthy subjects after single and multiple doses

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

A single-dose study to define tiagabine pharmacokinetics in pediatric patients with complex partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

A double-blind, placebo-controlled trial of tiagabine given three-times daily as add-on therapy for refractory partial seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Pharmacokinetics and safety of tiagabine in subjects with various degrees of hepatic function

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

1 reference

7 January 2021

Tiagabine: The Safety Landscape

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Safety of tiagabine: summary of 53 trials

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Review of controlled trials of gabitril (tiagabine): a clinician's viewpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

1 reference

7 January 2021

Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Tiagabine monotherapy in the treatment of partial epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

1 reference

7 January 2021

The pharmacokinetics of tiagabine in healthy elderly volunteers and elderly patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

Pharmacokinetics of tiagabine as add-on therapy in patients taking enzyme-inducing antiepilepsy drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0920-1211%2800%2900149-2

7 January 2021

10.1016/S0920-1211(00)00149-2

Identifiers

DOI

1 reference

30 July 2017

1 reference